Cost-effectiveness of applying high-sensitivity troponin I to a score for cardiovascular risk prediction in asymptomatic population.
Paul JülicherNataliya MakarovaFrancisco OjedaIsabella GiusepiAnnette PetersBarbara ThorandGiancarlo CesanaTorben JørgensenAllan LinnebergVeikko V SalomaaLicia IacovielloSimona CostanzoStefan SöderbergFrank KeeSimona GiampaoliLuigi PalmieriChiara DonfrancescoTanja ZellerKari KuulasmaaTarja TuovinenFelicity LamrockAnnette Conrads-FrankPaolo BrambillaStefan BlankenbergUwe SiebertPublished in: PloS one (2024)
Adding a person's hsTnI value to SCORE can impact clinical decision making and eventually improves QALYs and is cost-effective compared to CVD prevention strategies using SCORE alone. Stratifying SCORE risk classes for hsTnI would likely offer cost-effective alternatives, particularly when targeting higher risk groups.
Keyphrases